27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Gainers
- CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 billion.
- GlycoMimetics (NASDAQ:GLYC) shares moved upwards by 13.54% to $0.74. The market value of their outstanding shares is at $38.6 million.
- Kiora Pharmaceuticals (NASDAQ:KPRX) stock increased by 11.04% to $0.2. Today's trading volume for this security ended up closing at 193.4K shares, which is 1.9 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $7.3 million.
- Ainos (NASDAQ:AIMD) shares rose 10.49% to $1.79. The company's market cap stands at $34.8 million.
- ENDRA Life Sciences (NASDAQ:NDRA) shares increased by 7.49% to $0.33. The market value of their outstanding shares is at $20.8 million.
- Cidara Therapeutics (NASDAQ:CDTX) shares moved upwards by 6.99% to $0.82. The market value of their outstanding shares is at $57.8 million.
Losers
- HTG Molecular Diagnostics (NASDAQ:HTGM) shares declined by 10.9% to $0.62 during Tuesday's after-market session. The market value of their outstanding shares is at $6.8 million.
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares declined by 7.12% to $19.31. The market value of their outstanding shares is at $17.3 million.
- Statera BioPharma (NASDAQ:STAB) stock decreased by 6.26% to $0.15. The company's market cap stands at $7.5 million.
- NeuroOne Medical Tech (NASDAQ:NMTC) stock decreased by 6.1% to $1.85. The market value of their outstanding shares is at $29.9 million.
- Summit Therapeutics (NASDAQ:SMMT) stock declined by 5.93% to $1.27. The company's market cap stands at $255.5 million.
- Revelation Biosciences (NASDAQ:REVB) stock decreased by 5.02% to $0.3. The company's market cap stands at $7.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!